Integrated Kidney Care of Virginia LLC
KCE Located In: Virginia and North Carolina
Participant Groups and Providers
PENINSULA KIDNEY ASSOCIATES PC
DANIEL STEPHENSON
HOANG HAI NGUYEN
JOANN SIU-POST
LEI CHEN
MERFAKE SEMRET
OLAYIWOLA AYODEJI
SHUPING WANG
YOLANDA BROOKS
ALBEMARLE NEPHROLOGY PLLC
GREG WARREN
LORI KITNER
RAVI RAMSAMOOJ
RICHMOND NEPHROLOGY ASSOCIATES INC
AMBER ANGELIDIS
ANGELA HARVEY
ARI HIRSCH
ASHIF JETHAVA
ASHLEY MCKOSKY
CHRISTOPHER ACKER
DARAN GLENN
HARRY PEPPIATT
JESSICA BARTLAM
KARL KOENIG
KENDALL WEINERT
LEIGH WEINERT
MIRZA BAIG
PHILLIP HARTLE
SAJID GEORGE
SATISH PATEL
SHREYANK TRIPATHI
SRIKANTH KUNAPARAJU
STACIE SMITH
TIDEWATER KIDNEY SPECIALISTS INC
ANGELA GARCIA
ANITHA MURTHY
BHUPINDER PRAJAPATI
DANIEL RAKOWSKI
DAWN BETHEA
HAIDR AGHA
HOOMAN SADR
KIRANJIT DHILLON
KYLE VAUGHN
LIWEI HUANG
MADHU KOLLI
MALIK ANJUM
MARTHA VERSPRILLE
MELBETH LUSICA
STEVEN LEWINSKI
WEI ZHAO
YURY KALMANOVICH
MID-ATLANTIC KIDNEY CENTER
BRENDA HALSTEAD
GUITA GHADIRI
LOZINA DANEVA
RICHARD GAYLE
ROSLA ROYAL
SANDY GIBSON
WILSON NEPHROLOGY-INTERNAL MEDICINE PA
ANWAR AL-HAIDARY
LORIE COLLIER
CAROLINA NEPHROLOGY PA
AJAY SHREENATH
ROBERT KEMP
WILL BYNUM, M. D., P.A.
ROBERT BYNUM
NIRAV JASANI
Preferred Groups and Providers
VILLAGEHEALTH DM LLC
ABIMBOLA TREPANIER
GERTRUDE FRIMPONG
JENNIFER HEVENER
LAUREN FROEDE
MALLORY SANDRIDGE
MARTHA MOROLARI
REBECCA WATERS
RELINDIS NSOFON MUTIA
TESSA BURRUS-SANDERS
TUESDAY SAUER
TUESDAYE CURLING
RIVERSIDE HOSPITAL INC
CAPITAL PALLIATIVE CARE CONSULTANTS LLC
CATHERINE MCGRADY
CHARISSA BOYD
CHRISTIANA ROBERTS
JOAN PANKE
SENTARA ENTERPRISES
CAPITAL HOSPICE
Governing Body Designees
Clinical and Administrative Leadership
Mauren Paisley
Primary Contact & Administrative Leader
Director, DaVita IKC
Hooman Sadr
KCE Clinical Leader
Tidewater Kidney Specialists, Inc
Quality Measures
Information for the following performance measures will be available by February 1st, 2024.
- The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
- The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
- Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.
Shared Savings and Losses
Information for the following performance measures will be available by February 1st, 2024.
- Total amount of Shared Savings or Shared Losses per Performance Year
- Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
- Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year
For a full list of facilities and joint ventures, please click here.
For more information on CKCC, click here.